Latest Acquisition Strategy News

De.mem Limited has extended its growth streak with record quarterly cash receipts of approximately $10.4 million, a 31% increase year-on-year, alongside positive operating cash flow of $504,000 for the March 2026 quarter.

Golden State Mining Limited has reinforced its leadership and maintained disciplined exploration efforts across its Western Australian projects, holding a cash balance of $1.3 million at the end of March 2026.

Emmerson Resources has amended its acquisition scheme deed with Pan African Resources, nominating a Pan African subsidiary as the acquiring party while keeping the share exchange ratio intact.

Turnstone Resources has confirmed promising high-grade gold and copper mineralisation from initial rock chip sampling at its newly acquired Klinten Project in Southern Sweden, setting the stage for a targeted drill program later this year.

OD6 Metals has secured a strategic foothold in the US critical minerals market by acquiring the Quinn Fluorspar Project in Nevada, delivering ultra-high-grade assay results and commencing systematic exploration. Meanwhile, metallurgical progress at its Splinter Rock rare earths project and new copper targets at Gulf Creek underpin a diversified critical minerals portfolio.

Krakatoa Resources has restructured its acquisition of the Zopkhito Antimony-Gold Project in Georgia, adopting a staged earn-in model that reduces upfront payments and prioritises capital deployment into exploration and development activities for 2026.

WhiteHawk Limited has raised A$1.5 million through a share placement to fund integration and growth of its newly acquired Quixxi Clarity AI platform, marking a strategic push into the AI governance market.

Cobre Limited has kicked off a major 40,000-metre drilling campaign at its Sierra Atacama copper project in Chile, aiming to convert its existing NI 43-101 resource to JORC compliance and explore opportunities for a larger open-pit operation.

Yancoal Australia is set to acquire an 80% stake in the Kestrel Coal Mine for US$1.85 billion upfront plus up to US$550 million in contingent payments, significantly boosting its metallurgical coal portfolio and production scale in Queensland.

Argent BioPharma has finalized the acquisition of CannPal Animal Therapeutics, securing a Phase 3 veterinary epilepsy asset with near-term commercial prospects and an option to acquire the Neuvis® drug delivery platform, enhancing its neurological portfolio and U.S. market ambitions.

Sultan Resources Ltd (ASX: SLZ) has successfully listed on the US OTCID Market under the code SLZRF, aiming to increase liquidity and attract North American investors. The move supports the company’s strategy to expand its presence in the precious and critical metals sectors.

Little Green Pharma has issued a supplementary scheme booklet updating Cannatrek shareholders on the acquisition progress, including a revised timetable and the termination of a planned sale and leaseback of its WA production facility. Both companies’ boards continue to recommend the scheme, supported by an independent expert’s positive assessment.